NSCLC ADENOCARCINOMA

Clinical trials for NSCLC ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new NSCLC ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for NSCLC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

New hope for advanced lung cancer: atamparib trial launches

Disease control Not yet recruiting

This study tests an experimental drug, atamparib, in people with advanced non-small cell lung cancer (a common type of lung cancer) that has spread and stopped responding to standard treatments. The trial has two parts: first, finding the safest dose, then testing how well it wor…

Matched conditions: NSCLC ADENOCARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: Nerviano Medical Sciences (Shanghai) Ltd. • Aim: Disease control

Last updated May 17, 2026 03:13 UTC

NSCLC ADENOCARCINOMA

Get alerted when new NSCLC ADENOCARCINOMA trials appear

New hope for advanced lung cancer: atamparib trial launches